MedPath
TGA Approval

ENSPRYNG satralizumab 120 mg/1 mL solution for injection in pre-filled syringe (326047)

326047

ENSPRYNG satralizumab 120 mg/1 mL solution for injection in pre-filled syringe

Roche Products Pty Ltd

November 17, 2020

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/0565b3480e119d7dbbb5b5cbee3f57eb.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/894583f17c2d41e6386708381e8cd723.pdf

Active Ingredients

satralizumab

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ENSPRYNG satralizumab 120 mg/1 mL solution for injection in pre-filled syringe (326047) - TGA 批准文号 | MedPath